PT1515714E - Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico - Google Patents

Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico Download PDF

Info

Publication number
PT1515714E
PT1515714E PT03732804T PT03732804T PT1515714E PT 1515714 E PT1515714 E PT 1515714E PT 03732804 T PT03732804 T PT 03732804T PT 03732804 T PT03732804 T PT 03732804T PT 1515714 E PT1515714 E PT 1515714E
Authority
PT
Portugal
Prior art keywords
cosmetic
treatment
therapeutical
compounds
nutraceutical
Prior art date
Application number
PT03732804T
Other languages
English (en)
Inventor
Giancarlo Cravotto
Original Assignee
Medestea Res & Production S P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2002TO000521A external-priority patent/ITTO20020521A1/it
Priority claimed from ITTO20021049 external-priority patent/ITTO20021049A1/it
Application filed by Medestea Res & Production S P filed Critical Medestea Res & Production S P
Publication of PT1515714E publication Critical patent/PT1515714E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03Monocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/02Acyclic alcohols with carbon-to-carbon double bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/24Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT03732804T 2002-06-17 2003-06-16 Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico PT1515714E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002TO000521A ITTO20020521A1 (it) 2002-06-17 2002-06-17 Procedimento per la preparazione di acidi policosanoici e policosanoli
ITTO20021049 ITTO20021049A1 (it) 2002-12-03 2002-12-03 Composti ossigenati insaturi a lunga catena e loro impiego in campo terapeutico, cosmetico e nutraceutico.

Publications (1)

Publication Number Publication Date
PT1515714E true PT1515714E (pt) 2009-10-06

Family

ID=29738175

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03732804T PT1515714E (pt) 2002-06-17 2003-06-16 Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico

Country Status (10)

Country Link
US (1) US7649103B2 (pt)
EP (1) EP1515714B1 (pt)
CN (1) CN1665495A (pt)
AT (1) ATE439127T1 (pt)
AU (2) AU2003240189A1 (pt)
DE (1) DE60328785D1 (pt)
ES (1) ES2329888T3 (pt)
PT (1) PT1515714E (pt)
RU (1) RU2331415C2 (pt)
WO (2) WO2003106397A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005047221A1 (en) * 2003-11-17 2005-05-26 Dsm Ip Assets B.V. Process for the preparation of aliphatic primary alcohols and intermediates in such process
WO2006042835A1 (en) * 2004-10-18 2006-04-27 Dsm Ip Assets B.V. Process for the preparation of aliphatic primary alcohols and related intermediates in such process
WO2009133586A1 (ja) * 2008-04-28 2009-11-05 有限会社アンティアンティ アルツハイマー病の治療医薬
WO2010103549A2 (en) * 2009-03-12 2010-09-16 Godavari Biorefineries Ltd A method of obtaining policosanols from natural material
FR2950061B1 (fr) 2009-09-11 2013-12-20 Coatex Sas Monomeres associatifs a base de polycosanols, epaississants associatifs correspondants et leurs utilisations
CN102115425A (zh) * 2009-12-30 2011-07-06 重庆华邦胜凯制药有限公司 一种直链烯醇及其制备方法
EP2621883B1 (en) * 2010-10-01 2017-09-27 DSM IP Assets B.V. Improved synthesis of peretinoin
WO2012105476A1 (ja) * 2011-01-31 2012-08-09 日本臓器製薬株式会社 抗がん剤による末梢神経障害の予防又は治療剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU546872B2 (en) * 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
CU22723A1 (es) * 1997-04-02 2002-02-28 Dalmer Lab Sa Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
CA2340223A1 (en) * 1998-08-12 2000-02-24 Morinaga Milk Industry Co., Ltd. Nutritional compositions for preventing or treating hyperlipoproteinemia
ATE384518T1 (de) * 2000-01-31 2008-02-15 Haerting S A Zusammensetzungen enthaltend phytosterol- und policosanolester von fettsäuren zur herabsetzung des cholesterol- und triglyceridspiegels
JP2002069111A (ja) * 2000-06-13 2002-03-08 Japan Science & Technology Corp 重合分子鎖の作成方法

Also Published As

Publication number Publication date
US20050234127A1 (en) 2005-10-20
RU2005100847A (ru) 2005-10-10
AU2003240189A1 (en) 2003-12-31
ES2329888T3 (es) 2009-12-02
US7649103B2 (en) 2010-01-19
CN1665495A (zh) 2005-09-07
AU2003240187A1 (en) 2003-12-31
WO2003105822A1 (en) 2003-12-24
RU2331415C2 (ru) 2008-08-20
DE60328785D1 (de) 2009-09-24
ATE439127T1 (de) 2009-08-15
WO2003105822A8 (en) 2004-04-08
WO2003106397A1 (en) 2003-12-24
EP1515714B1 (en) 2009-08-12
EP1515714A1 (en) 2005-03-23

Similar Documents

Publication Publication Date Title
Galanakis et al. Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent antiinflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity
UA109252C2 (uk) Сірковмісні ліпіди для застосування як харчових добавок або медикаментів
ES2102502T3 (es) Esteres 7-cromanilicos de fenoles y acidos benzoicos que tienen actividad de tipo retinoide.
DK0752855T3 (da) Anvendelse af fedtsyreestere som bioadhæsive substanser
CA2043137A1 (en) Essential fatty acid treatment
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
RU2013145701A (ru) Способ лечения нейротравмы
ES2255467T1 (es) Acidos grasos de cadena media, gliceridos y analogos como estimuladores de la eritropoyesis.
WO2002018324A3 (en) Immunoregulatory compounds, derivatives thereof and their use
WO2003105822A8 (en) LONG CHAIN UNSATURATED OXYGEN COMPOUNDS AND THEIR USE IN THERAPEUTICS, COSMETICS AND NUTRACEUTICS
RU2013108944A (ru) Ингибиторы faah периферически-ограниченного действия
WO2008093772A1 (ja) 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
US20160243011A1 (en) Formulations Comprising Idebenone, N-Acetyl-S-Farnesyl-L-Cysteine and Ergothioneine and Uses Thereof
JP5587333B2 (ja) 抗アクネ剤としての多価不飽和脂肪酸およびジオールエステル
AU2016219617A1 (en) Positively charged water-soluble prodrugs of aspirin
RU2742769C2 (ru) Амидопроизводные поликофеоилхинных кислот, способ их получения и их применения
KR870700065A (ko) 신규한 카본산 에스테르
ATE43348T1 (de) Acylierte cytidin-diphosphat-choline, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
RU2008138380A (ru) Использование dha и ara для получения композиции, предназначенной для регуляции экспрессии генов
RU2009102271A (ru) Производные фенилуксусной кислоты как ингибиторы цог-2(циклооксигеназы-2)
ATE341331T1 (de) Lipide zur änderung des abwehrsystems
RU2011152276A (ru) Моноэфиры и диэфиры аскорбиновой кислоты с ненасыщенными жирными кислотами и их косметическое применение
WO2008131863A3 (de) Ester von hexyldecanol mit kurzkettigen fettsäuren
DE502004004660D1 (de) Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff
WO2006083786A3 (en) Skin moisturizing compositions